
HIV Outcomes in Hepatitis B Virus Coinfected Individuals on HAART
Author(s) -
Helen Chun,
Octavio Mesner,
Chloe L. Thio,
Ionut Bebu,
Grace Macalino,
Brian K. Agan,
William P. Bradley,
Jennifer Malia,
Sheila A. Peel,
Linda L. Jagodzinski,
Amy C. Weintrob,
Anuradha Ganesan,
Mary Bavaro,
Jason D. Maguire,
Michael L. Landrum
Publication year - 2014
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000000142
Subject(s) - human immunodeficiency virus (hiv) , virology , medicine , hepatitis c virus , hepatitis b virus , hepatitis c , hepacivirus , virus , viral disease
Understanding the impact of hepatitis B virus (HBV) coinfection on HIV outcomes in the highly active antiretroviral therapy (HAART) era continues to be a critical priority given the high prevalence of coinfection and the potential for impaired immunologic, virologic, and clinical recovery.